State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization
Published: April 30, 2015
![Science News on light gray background](/-/media/PHD-Images/Science-News/science_news_default.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- Vascular dysfunction is a contributing factor in many diseases, including cardiovascular disease.
- Although much is known about the biochemistry of neovascularization, translation to clinical therapies is challenging.
- Development of relevant pre-clinical models is needed to test novel therapeutic strategies.
Supporting Materials
- Commentary: An Opus on the Science of Neovascularization by Douglas W. Losordo, MD
- Top Things to Know: Models for the Study of Angiogenesis and Tissue Vascularization